Where does ONCY stock trade?

Oncolytics Biotech Inc. (ONCY) is listed on NASDAQ.

What sector and industry is ONCY in?

Oncolytics Biotech Inc. operates in the Health Care sector, Biotechnology: Pharmaceutical Preparations industry.

What are analysts saying about ONCY?

Oncolytics Biotech Inc. has had 2 recent analyst actions on file. The most recent action was from Lake Street: Buy with a $700.00 price target on 2025-08-13. Recent price targets range from $300.00 to $700.00.

What companies are similar to ONCY?

Notable peers in the same industry include LEGN (Legend Biotech Corporation), PBYI (Puma Biotechnology Inc), FBIO (Fortress Biotech Inc.), MBRX (Moleculin Biotech Inc.). Compare ONCY side-by-side with any of them on Quantisnow.

How can I track ONCY on Quantisnow?

Quantisnow aggregates Oncolytics Biotech Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow ONCY to receive live email and push alerts on every new disclosure.

ONCY

NASDAQ

Oncolytics Biotech Inc.

SectorHealth CareIndustryBiotechnology: Pharmaceutical Preparations

$0.90+0.03 (+3.02%)

Follow Website

News25/Ratings2

Oncolytics Biotech Inc., a development stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. Its lead product is pelareorep, an immuno-oncology viral-agent for the treatment of solid tumors and hematological malignancies. The company has collaboration agreements with Merck KGaA and Pfizer Inc. to co-develop pelareorep in combination with paclitaxel and avelumab, a human anti-PD-L1 antibody for the treatment of hormone-receptor positive, human epidermal growth factor 2-negative metastatic breast cancer; and PrECOG LLC. The company was incorporated in 1998 and is headquartered in Calgary, Canada.

Price$0.90-0.03 (-2.80%)

01:30 PM07:45 PM

News · 26 weeks142+38%

2025-11-022026-04-26

Mix8390d

Other55(66%)
SEC Filings17(20%)
Insider11(13%)

Latest news

25 items

ONCY FAQ

6 questions

What does Oncolytics Biotech Inc. do?
Oncolytics Biotech Inc., a development stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. Its lead product is pelareorep, an immuno-oncology viral-agent for the treatment of solid tumors and hematological malignancies. The company has collaboration agreements with Merck KGaA and Pfizer Inc. to co-develop pelareorep in combination with paclitaxel and avelumab, a human anti-PD-L1 antibody for the treatment of hormone-receptor positive, human epidermal growth factor 2-negative metastatic breast cancer; and PrECOG LLC...
Where does ONCY stock trade?
Oncolytics Biotech Inc. (ONCY) is listed on NASDAQ.
What sector and industry is ONCY in?
Oncolytics Biotech Inc. operates in the Health Care sector, Biotechnology: Pharmaceutical Preparations industry.
What are analysts saying about ONCY?
Oncolytics Biotech Inc. has had 2 recent analyst actions on file. The most recent action was from Lake Street: Buy with a $700.00 price target on 2025-08-13. Recent price targets range from $300.00 to $700.00.
What companies are similar to ONCY?
Notable peers in the same industry include LEGN (Legend Biotech Corporation), PBYI (Puma Biotechnology Inc), FBIO (Fortress Biotech Inc.), MBRX (Moleculin Biotech Inc.). Compare ONCY side-by-side with any of them on Quantisnow.
How can I track ONCY on Quantisnow?
Quantisnow aggregates Oncolytics Biotech Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow ONCY to receive live email and push alerts on every new disclosure.